Skip to main content

Table 3 Ovarian reserve markers in patients before and after DHEA treatment

From: Dehydroepiandrosterone improves follicular fluid bone morphogenetic protein-15 and accumulated embryo score of infertility patients with diminished ovarian reserve undergoing in vitro fertilization: a randomized controlled trial

Paremeters Pre-treatmentn=42 Post-treatmentn=42 P-value
AMH (ng/ml) 1.01 ± 0.77 1.29 ± 1.09 .015
FSH (mIU/mL) 11.68 ± 6.62 9.45 ± 5.09 .036
Estradiol (pg/ml) 186.58 ± 142.19 110.79 ± 68.28 .002
DHEA-S (μg/mL) 1.24 ± 0.74 5.50 ± 3.48 .000
Testosterone(nmol/L) 0.74 ± 0.41 2.25 ± 1.28 .000
Antral follicle count 2.95 ± 1.38 3.21 ± 1.22 .054
  1. Data are presented as mean ± SD (standard deviation). P<.05 was considered as statistically significant.